Intuitive Surgical, Inc. financials

  1. Home
  2. Financials
  3. ISRG
ISRG CIK 0001035267

Source: EDGAR filings · Built 2026-06-02T03:20:08Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 2.49B 1.30B 749.60M 958.40M 1.75B 1.14B
EBITDA 3.56B 2.80B 2.17B 1.93B 2.13B 1.32B
Working Capital 7.77B 5.37B 6.23B 4.83B 4.70B 5.66B
Net Debt -3.20B -1.88B -2.66B -1.49B -1.20B -1.54B
Gross Margin 66.00% 67.46% 66.39% 67.44% 69.32% 65.65%
Operating Margin 29.27% 28.12% 24.80% 25.35% 31.89% 24.09%
Net Margin 28.38% 27.81% 25.24% 21.25% 29.85% 24.33%
Return on Equity (ROE) 16.02% 14.13% 13.51% 11.98% 14.32% 10.90%
Return on Assets (ROA) 13.96% 12.39% 11.64% 10.19% 12.58% 9.50%
Current Ratio 4.87× 4.07× 4.76× 4.40× 5.08× 6.86×
Debt-to-Equity 0.01× 0.01× 0.01× 0.01× 0.01× 0.01×
Effective Tax Rate 13.13% 12.58% 7.23% 16.33% 8.58% 11.62%
Cash Conversion Ratio 1.06× 1.04× 1.01× 1.13× 1.23× 1.40×
Accruals Ratio -0.01× -0.00× -0.00× -0.01× -0.03× -0.04×
SBC % of Revenue 7.83% 8.10% 8.32% 8.25% 7.87% 9.07%
CapEx Coverage 5.61× 2.17× 1.70× 2.80× 6.15× 4.35×
Free Cash Flow Per Share $6.87 $3.60 $2.10 $2.65 $4.78 $3.17

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 71.96× 81.30× 67.07× 72.70× 77.10× 92.76×
P/FCF 82.47× 144.92× 160.85× 100.23× 75.11× 86.11×
FCF Yield 1.21% 0.69% 0.62% 1.00% 1.33% 1.16%
EV / EBITDA 55.62× 65.70× 53.57× 47.33× 59.82× 217.57×
P/S 19.98× 22.29× 16.68× 14.93× 22.51× 66.28×
P/B 11.28× 11.33× 8.93× 8.41× 10.80× 29.68×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 10.06B 8.35B 7.12B 6.22B 5.71B 4.36B
Cost of Goods and Services Sold 3.42B 2.72B 2.39B 2.03B 1.75B 1.50B
Gross Profit 6.64B 5.63B 4.73B 4.20B 3.96B 2.86B
Research and Development Expense 1.31B 1.15B 998.80M 879.00M 671.00M 595.10M
Selling, General and Administrative Expense 2.38B 2.14B 1.96B 1.74B 1.47B 1.22B
Operating Expenses 3.70B 3.29B 2.96B 2.62B 2.14B 1.81B
Operating Income (Loss) 2.95B 2.35B 1.77B 1.58B 1.82B 1.05B
Income Tax Expense (Benefit) 434.80M 336.30M 141.60M 262.40M 162.20M 140.20M
Net Income (Loss) Attributable to Parent 2.86B 2.32B 1.80B 1.32B 1.70B 1.06B
Earnings Per Share, Basic $8.00 $6.54 $5.12 $3.72 $4.79 $3.02
Weighted Average Number of Shares Outstanding, Basic 356.90M 355.20M 351.20M 355.70M 356.10M 351.10M
Earnings Per Share, Diluted $7.87 $6.42 $5.03 $3.65 $4.66 $2.94
Weighted Average Number of Shares Outstanding, Diluted 362.70M 362.00M 357.40M 362.00M 365.80M 361.00M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 3.37B 2.03B 2.75B 1.58B 1.29B 1.62B
Assets, Current 9.78B 7.11B 7.89B 6.25B 5.84B 6.63B
Assets 20.46B 18.74B 15.44B 12.97B 13.55B 11.17B
Liabilities, Current 2.01B 1.75B 1.66B 1.42B 1.15B 965.20M
Liabilities 2.52B 2.21B 2.04B 1.86B 1.60B 1.41B
Stockholders' Equity Attributable to Parent 17.82B 16.43B 13.31B 11.04B 11.90B 9.73B
Common Stock, Shares, Outstanding 355.10M 356.60M 352.30M 350.00M 357.70M 353.10M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 3.03B 2.42B 1.81B 1.49B 2.09B 1.48B
Net Cash Provided by (Used in) Investing Activities 665.80M -3.27B -360.10M 1.37B -2.46B -940.60M
Payments for Repurchase of Common Stock 2.30B 0 416.30M 2.61B 0 134.30M
Net Cash Provided by (Used in) Financing Activities -2.36B 150.90M -287.60M -2.57B 43.00M -85.70M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ISRG CIK 0001035267), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

GLIBA

GCI Liberty, Inc.

PRI

Primerica, Inc.

AMTM

Amentum Holdings, Inc.